New cancer drug boosts effectiveness of chemotherapy-even in resistant tumours: Study Dr. Kamal Kant Kohli22 Aug 2025 10:00 PM ISTA groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a...
Merck's SpringWorks Therapeutics gets nod for Ogsiveo from European Commission for adults with Desmoid Tumors Ruchika Sharma22 Aug 2025 11:30 AM ISTStamford: SpringWorks Therapeutics, Inc., a healthcare company of Merck, has received marketing authorization from the European...
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients: Study Dr. Kamal Kant Kohli21 Aug 2025 11:30 PM ISTFor some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening...
Heart-healthy habits also prevent cancer, Alzheimer's, COPD, other diseases, Emory study finds Dr. Kamal Kant Kohli21 Aug 2025 9:00 PM ISTA new study from Emory University reveals that maintaining optimal cardiovascular health can significantly improve overall physical and psychological...
Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor Deeksha Bhandari21 Aug 2025 12:30 PM ISTIn this video, Dr. Akhil Kapoor, Medical Oncologist at Tata Memorial Centre, Varanasi, Uttar Pradesh, discusses a real-world case study of...
Artificial intelligence-based screening of breast cancer by mammography microcalcification accurate: Study Dr. Kamal Kant Kohli20 Aug 2025 8:30 PM ISTEach year, millions of women undergo mammography to screen for breast cancer, yet tiny calcium specks-known as microcalcifications-often evade...
tsRNAs emerge as powerful non-invasive biomarkers in liquid biopsy, reveals research Dr. Kamal Kant Kohli19 Aug 2025 8:15 PM ISTA new review highlights the transformative potential of transfer RNA-derived small RNAs (tsRNAs) in the field of liquid biopsy, emphasizing their role...
Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer Ruchika Sharma19 Aug 2025 2:15 PM ISTPrinceton: SystImmune Inc., a clinical-stage biotechnology company, and Bristol Myers Squibb have announced that the U.S. Food and Drug...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
New methods show how fast breast cancers grow and how surgery delays affect cancer staging: Study Dr. Kamal Kant Kohli18 Aug 2025 8:45 PM ISTUsing a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how...
Global rise in many Early-Onset GI cancers with colorectal cancer leading the trend, reveal two Dana-Farber reviews Dr. Kamal Kant Kohli17 Aug 2025 9:00 PM ISTEarly-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of...
Study explores current state and research innovation in endometrial cancer screening Dr. Kamal Kant Kohli15 Aug 2025 10:00 PM ISTEndometrial cancer (EC) ranks among the top three gynecologic malignancies globally, with rising incidence in younger populations driven by obesity,...
